Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001558370-24-015059
Filing Date
2024-11-08
Accepted
2024-11-08 16:14:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 sngx-20241108x424b3.htm 424B3 1407210
2 GRAPHIC sngx-20241108x424b3_a001.jpg GRAPHIC 6857
  Complete submission text file 0001558370-24-015059.txt   1418128
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-274265 | Film No.: 241440742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)